Option Therapeutics (OPTN) files for downsized 1.82M share IPO at $10-$12/sh Mar 16, 2026 06:09AM
Option Therapeutics (OPTN) files for 2.27M share IPO at $10-$12/sh Jan 26, 2026 06:05AM
OptiNose (OPTN) Reports In-Line Q4 EPS Mar 26, 2025 07:31AM
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating OptiNose, Inc. Buyout Mar 20, 2025 05:32PM
Lake Street Capital Markets Downgrades Optinose (OPTN) to Hold Mar 20, 2025 09:14AM


Mar 20, 2025 07:57AM Paratek Pharmaceuticals (PRTK) to Acquire OptiNose (OPTN)
Mar 19, 2025 09:25PM Paratek Pharmaceuticals to Acquire Optinose
Jan 15, 2025 07:01AM OptiNose (OPTN) Announces Preliminary Unaudited Fourth Quarter 2024 XHANCE Net Revenue of $22.4 Million
Jan 3, 2025 06:06AM Optinose (OPTN) PT Raised to $18 at H.C. Wainwright
Dec 26, 2024 07:00AM OptiNose (OPTN) Announces 1:15 Reverse Share Split
Nov 13, 2024 10:25AM Optinose (OPTN) PT Lowered to $1 at Piper Sandler
Nov 12, 2024 07:09AM OptiNose (OPTN) Tops Q3 EPS by 5c, Misses on Revenue; Offers FY24 Guidance
Oct 7, 2024 05:00PM OptiNose (OPTN) Appoints Terry Kohler as CFO
Aug 8, 2024 07:19AM OptiNose (OPTN) Tops Q2 EPS by 1c ; Offers Guidance